INTRODUCTION
One-third of the world's population is infected with Mycobacterium tuberculosis, and 3 million human's deaths are annually attributed to the organism. Although there is a very large global pool of infected individuals and considerable chromosomal heterogeneity, based on restriction fragment length polymorphism (RFLP) patterns, generated by probing with mobile insertion elements, studies of drug resistance and pathogenesis have raised the possibility that synonymous (silent) nucleotide substitutions in structural genes may be limited (1) (2) (3) (4) (5) .
Isoniazid, a first-line anti-tuberculotic drug, has a simple chemical structure consisting of a pyridine ring and a hydrazide group. The bifunctional bacterial enzyme catalase-peroxidase (katG) converts isoniazid to a range of oxygenated and organic toxic radicals that attack multiple targets in the mycobacterial cell. The bestcharacterized target of these radicals is the cell wall mycolic acid, but DNA, carbohydrates, lipids, and DNA metabolism may be targeted as well (1, 2) .
The lack of neutral mutations in structural genes indicates that M. tuberculosis is evolutionarily young and has recently spread globally. Species diversity in M. tuberculosis is largely caused by rapidly evolving insertion sequences, which means that mobile element movement is a fundamental process generating genomic variation in this pathogen. M. tuberculosis is contagious, and spreads through the air; person with active tuberculosis infects, on average, 10-15 others every year. One in 10 people infected with M. tuberculosis bacilli will become sick with active tuberculosis in his or her lifetime. M. tuberculosis is responsible for more deaths than any other single infectious organism; there are more than 8 million new cases and 1.7 million deaths annually. European Union countries report 23% of all new cases, and Kazakhistan, Romania, the Russian Federation, Turkey, Ukraine and Uzbekistan account for 73% of the total number of cases (2, 3, 5, 6) .
Sreevatsan et al. studied 26 structural genes of 842 isolates and suggested a broad evolutionary scenario for mycobacteria organisms, characterized by katG codon 463 and gyrA codon 95, in which M. tuberculosis could be split into three principal genotypic groups (PGGs), inspection of the sequence data revealed that only the variants at katG codon 463 and gyrA codon 95 were present at high frequency. These two sites apparently do not participate in antibiotic resistance and, hence, they were used as genetic markers that record the history of organism divergence (7) . All members of the M. tuberculosis complex were assigned to one of three distinct genotypic groups, based on the combination of polymorphisms located at these two sites (Table 1) (7): group 1 with KatG463 CTG (Leu), GyrA95 ACC (Thr); group 2 with KatG463 CGG (Arg), GyrA95 ACC (Thr); and group 3 with KatG463 CGG (Arg), GyrA95 AGC (Ser) (7) .
M. tuberculosis organisms, belonging to group 1, have katG and gyrA sequences indistinguishable from those of M. microti, M. africanum, and M. bovis. One subgroup of genetic group 1, the Beijing/W lineage, has been widely studied because of its worldwide distribution and association with outbreaks (1) .
Polymorphism located at katG codon 463 was identified by automated DNA sequencing, PCR-RFLP with restriction endonuclease NciI or MspI, dot-blot hybridization and also a real-time PCR assay based on the use of molecular beacons (6, (8) (9) (10) (11) . Polymorphism occurring at gyrA codon 95 was indexed by automated DNA sequencing (7, 11) .
The value of this classification was further supported by typing according to the spoligotyping technique, and became a well-established and widely used scheme applied in the field of molecular epidemiology of tuberculosis (11) (12) (13) .
The susceptibility of M. tuberculosis to isoniazid and the Arg to Leu mutation at KatG463 are not associated (14) .
With an evolutionary bottleneck approximately 15.000 to 20.000 years ago, possibly around the time of speciation of M. tuberculosis, PGG1 is thought to be evolutionarily older. Strain type of H37Rv is classified as a member of genetic group 3, and the Beijing is a subgroup of the genetic group 1 (7, 15) . As clustering is considered a marker of increased transmissibility, a higher virulence of group 1 and group 2 organisms compared to group 3 has been suggested (7, 9) .
Patients infected by principal genetic group 1 isolates were more likely to have extrathoracic involvement than those infected by group 2 isolates. However, this association was driven by the association of infection by the Beijing/W lineage isolates, a subgroup of group 1, with extrathoracic involvement. In addition, it was found that patients of Asian origin were the largest. Infections caused by isolates from group 1 are more likely to have Arjomandzadegan M, Titov LP, Surkova LK, Farnia P, Sheikholeslami F, Owlia P, Eshghinejad A, Farazi AA, Eshrati M, Kahbazi M, Ahmadi A, Shojapur M.
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resulted from recent transmissions than infections caused by isolates belonging to the other two groups (1).
Aim of the work was the comparison of PGG situation in three distinct groups for evaluation of geographic parameter on M. tuberculosis isolates typing.
MATERIALS and METHODS

Research Material and M. tuberculosis Isolates
Fifty seven isolates from Iran and 35 isolates from Belarus were collected. The research material was sputum obtained from pulmonary tuberculosis patients from different regions of Belarus and Iran.
All the patients examined had clinically confirmed tuberculosis and proven registrations of clinical diagnostic examinations, such as chest X-ray, PPD, couch, weight loss etc. Patient sputum samples were cultured on Löwenstein-Jensen medium and grown colonies that were identified to the species level using TCH (2-thiophene carboxylic acid) and PN99B (paranitrobenzoic acid) selective media or by standard biochemical procedures.
Drug Susceptibility Testing
The antimicrobial drug susceptibility tests (AMST) were performed by World Health Organization (WHO) standard conventional proportional method preferably on Löwenstein-Jensen medium using the critical drug concentrations. Susceptibility testing was performed by the absolute concentration method. A microbial suspension containing 5 x 10 8 organisms/mL was prepared according to McFarland turbidity standards and was diluted 1/10; then, 0.2 mL of the dilution was added to Löwenstein-Jensen medium with or without a drug. The culture tubes were incubated at 37°C, and growth was monitored after three weeks of incubation and assessed as described WHO (2) . All isolates were tested for susceptibility to first line drugs as rifampicin 40 µg/mL, isoniazid 1 µg/mL, ethambutol 2 µg/mL and streptomycin 10 µg/mL, on slants with H37Rv strain of M. tuberculosis as the positive control, using the BAC-TEC system in level III laboratory. An isolate was considered resistant to isoniazid when bacterial growth occurred in the presence of a concentration of 1 µg of isoniazid per mL. As recommendations of WHO those strains resistant to at least isoniazid and rifampicin (MDR) were tested for their susceptibility to any fluoroquinolone and at least one of three injectable secondline drugs (capreomycin, kanamycin, and amikacin) in the BACTEC system for detection of XDR isolates. This definition of XDR-TB was agreed by the WHO Global Task Force on XDR-TB in October 2006 (3) .
DNA Purification and PCR
DNA purification from isolates performed by using of modified Chelex 100 method (15) . In brief, it was per-formed by solving of 3-4 colonies of fresh culture of isolate in 270 mL TAE buffer (1x) and heating in 95°C for 45 minutes, following by three 10-minutes centrifugations in 14.000 rpm for totally removal of Chelex 100 that would interferes to PCR reaction.
PCR performed in 50 µL of a reaction mixture containing 50 mM KCl, 10 mM Tris (pH 8.0), 1.5 mM MgCl2 (or Buffer of Amersham), 5 µM of deoxynucleoside triphosphates (dNTPs), 1U Taq polymerase, 20 pmoles of each set of primers as mentioned in Table 2 , and 3-6 µM of chromosomal DNA. The thermocycler parameters run as requiring.
The products were checked on the gel electrophoresis and amplified katG and gyrA segments were purified. The resultant DNA amplifications would be used for sequencing.
PCR-RFLP
In this study, PCR-Restricton fragment length polymorphism analysis was done as described previously (5, 6) .
DNA Sequencing
Detection of mutation in GyrA95 and point mutations detected by PCR-RFLP, were verified by sequence method.
PCR reaction was performed with different primers and conditions as shown in Table 2 . PCR products were detected by 1.5% agarose-ethidium bromide gel electrophoresis and extracted from agarose gel by DNA extraction kit (Fermentas, K0513) according to the manufacturer's instructions. Extracted DNA concentrations were measured by nucleic acid analyzer (DU 730, Life Science UV/Vis spectrophotometer).
837bp extracted fragment of katG gene (from nucleotide number of 571 to 1408) and 194 bp of gyrA gene were amplified in a Rotor-Gene (RG-3000, Corbett Research Inc.) by Thermo-Sequenase Cy5 Dye Terminator Sequencing Kit (GE Healthcare 27-2682-01). Amplification for sequence was performed by oligonucleotide primer that was designed as Table 2 , from the M. tuberculosis H37Rv genome sequence, by help of server programs. Sequence was done directly using an automatic DNA sequencer (Amersham auto sequencer).
Detection of Principle Genetic Groups
The SNPs at KatG463 and GyrA95 were investigated by PCR assay and sequencing. Isolates were assigned to one of the three principal genetic groups based on the SNPs found in KatG463 and GyrA95 delineated by Sreevatsan et al., as group 1 (KatG463 CTG, GyrA95 ACC), group 2 (KatG463 CGG, GyrA95 ACC), or group 3 (KatG463 CGG, GyrA95 AGC).
Polymorphism at codon 95 of the gyrA gene was detected by PCR amplification of a 194 bp DNA fragment Determination of principal genotypic groups among susceptible, MDR and XDR clinical isolates of Mycobacterium tuberculosis in Belarus and Iran with primers gyrA ( Table 2 ). All amplicons were sequenced as above mentioned method by reverse primer of gyrA (Table 2) .
RESULTS
From 140 Belarusian samples suffering active tuberculosis that have been referred, 70% were women and 30% men, and male/female ratio was 2.3. Furthermore, 42.5% of the patients suffering primary tuberculosis and 57.5% have secondary form of tuberculosis. Patients originated from different regions of Belarus (Brest, Magiliev, Gomel, Gorodna and Vitebsk) and different regions of I.R of Iran were admitted to the Reference Laboratory.
DNA extraction by Chelex 100 was the best material for purification and maintenance DNA for long time. As shown in Table 1 , PCR method using primers for amplification of 620 bp amplicon, could further detect all resistant and susceptible isolates that identified by conventional methods.
DNA sequencing of the katG gene from randomly selected isolates verified 100% sequence accuracy of the point mutations, detected by PCR-RFLP.
All of XDR and MDR isolates, suffered mutation in nucleotide 944 as G944C (AGC → ACC) in aminoacid Ser315Thr. Standard strain H37Rv has non mutated codon. In M. bovis both of sites were mutated.
In this study, M. tuberculosis isolates were classified in three genotypic groups on the basis of the presence of single nucleotide polymorphisms in codon 463 of the katG gene (KatG463) and codon 95 of the gyrA gene (GyrA95) ( Tehran samples that were selected MDR isolates had a pattern as: 9 (53%), 6 (35.2%), 2 (11.8%) (PGG 1, 2, and 3, respectively) .
Among the 31 XDR-isolates, 15 (48.4 ± 9.1%) belonged to the first group, 12 (38.7 ± 8.9%) and 4 (12.90 ± 6.0%) respectively belonged to the 2 nd and 3 rd groups (p< 0.05).
These data ( 8.4%) group of 3. There was no relation between PGG and resistance to isoniazid, but most of the identified isolates belonged to PGG 1 (p< 0.05).
In susceptible group, there was not any significant difference between three genetic groups. Frequency of principle genetic groups among MDR isolates of Iran-Tehran was like to Belarusian isolates.
Overall, as shown in Table 3 , resistant isolates in this study, from both regions of Belarus and Iran, had similar situation about PGG analysis (dominant PGG 1) but susceptible strains belonged to PGG 2 and 3. There is no relation between PGG typing and geographic region, but it seems that PGG status is related to drug resistance.
DISCUSSION
The group 1 isolates showed more frequency in MDR and XDR (54.8 and 48.4%, respectively) rather than susceptible and standard strains (34 and 33%, respectively). Dominance of PGG 1 organisms provides an additional support for the hypothesis that the group is evolutionarily older than groups 2 and 3, and therefore has more time to accumulate divergence and resistance (16) .
Due to the fact that highly resistant genetic variant Beijing, belonging to the first genetic group, spreads rapidly, and it is currently a public health threat in many countries, it can be assumed to spread on the territory of Belarus. The majority of the Iranian MDR isolates were belonged to group 1 (53.0 ± 21.9%). Supporting this provision is incidence of isolates in first genetic group, which dominates among the analyzed MDR and XDR isolates in our study (p< 0.05).
The Beijing genotype of M. tuberculosis is a virulent strain that has originated out of East Asia, and has disseminated around the world. One potential explanation for the increased virulence in Beijing genotype is the production of phenolglycolipid (PGL), a surface antigen that suppresses the Th1 response. PGL is produced in Beijing strains from principle genetic group 1, but it is not produced by members of the other PGGs (2 and 3), such as M. tuberculosis H37Rv (17) .
The Beijing genotype is strongly associated with drug resistance and outbreaks, including multidrug resistance (MDRTB) and extensive-drug resistance (XDR-TB) (1) . This finding accords with our results in this work.
Among isolates from patients living in the city of Minsk and Mogilev, they constitute the majority (75% and 88% respectively). However, the structure of PGG isolates from patients with tuberculosis from prisons is no different from those isolates throughout the country. Overall, the results indicate that M. tuberculosis strains belonging to group 2 and group 3 are predominant among susceptible isolates.
This work describes the development of a simple and specific PCR-based typing method that differentiates subspecies of the M. tuberculosis and segregates them from various clinically important mycobacteria other than tuberculosis (MOTT) species. If confirmed, the discovery of three distinct M. tuberculosis lineages with variable epidemiologic and clinical manifestations would have important implications for public health control strategies, studies of bacterial virulence, and mathematical modeling of tuberculosis epidemiology.
To our knowledge, this is the first study describing the distribution of Iranian and Belarusian M. tuberculosis isolates among the three groups delineated by the katG and gyrA polymorphisms.
Infections caused by isolates from group 1 are more likely to have resulted from recent transmissions than infections caused by isolates belonging to the other two groups. Public health approaches and tuberculosis transmission models may benefit from data in the context about the three genetic groups (7) .
From point of application, the test has three benefits:
Detection of principle genetic groups, fast detection of M. tuberculosis in sample and differentiation from MOTT by determination of 620 bp fragment of katG gene, and simultaneous detection of mutation in KatG315 that determinates resistance to isoniazid [with a high percentage of precision (5)].
It seems that PGG typing is closely related to resistance status of isolates rather than geographic origin. Supporting this provision is predominance of PGG 1 in resistant isolates that was significantly higher than other groups in our study (p< 0.05). The PGG typing is a good and fast tool for detection of more important types based on clinical aspects.
